EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Active bone marrow dose reconstruction in a large‐scale cohort study of cancer patients treated with photon radiotherapy

Keith T Griffin iD, Kishan J Pithadia, Yeon Soo Yeom, Lior Braunstein, Kelly L Bolton, Lindsay M Morton, Choonsik Lee

Journal of Applied Clinical Medical Physics · 2026-03 · 27 (3)

DOI: 10.1002/acm2.70494 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 24.02.2026. Verfasst von Keith T Griffin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Photons, Bone Marrow, Radiotherapy Planning, Computer-Assisted, Organs at Risk. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have investigated the dose‐response relationship between external beam radiotherapy (EBRT) and leukemia by reconstructing the mean active bone marrow (ABM) dose as part of the exposure assessment. However, no prior study has leveraged electronic medical records (EMR) to reconstruct ABM dose and dose‐volume in an EBRT patient population.

Purpose

To support future studies on the relationship between radiation exposure and adverse health effects among EBRT patients, we demonstrate methods to retrospectively calculate ABM dose and dose‐volume metrics in a large patient cohort using EMR.

Methods

We retrieved complete EMR for 639 individuals (five pediatric and 634 adult) from a retrospective cohort of cancer patients treated with photon radiotherapy between 2003 and 2011, covering a wide range of treatment sites and target volumes. Using a previously published methodology by our group, bone site contours were derived for each patient treatment session via three‐dimensional skeletal registration with a habitus‐matched computational phantom. Segmentation accuracy was assessed analytically and by visual inspection of the patient‐phantom skeletal overlap. ABM dose and dose‐volume metrics were computed using the derived skeletal segmentation and the dose distribution calculated by the treatment planning system.

Results

Analytically and visually acceptable skeletal segmentation was achieved for 478 patients (three pediatric, 475 adult). Across all treatment sessions, pelvic irradiation resulted in the highest mean ABM dose per prescribed dose (distribution 25th–75th percentile: 0.1820–0.2870 Gy/Gy_Rx, n = 183), while intracranial irradiation produced the lowest among the categorized field types (0.0030–0.0391 Gy/Gy_Rx, n = 37). Dose‐volume analyses indicated that the mean ABM dose estimate provides a limited characterization of the ABM dose distribution, with most patients having a 99th percentile dose to marrow volume that was at least one order of magnitude higher than the mean dose estimate.

Conclusions

This study presents a scalable EMR‐based approach for reconstructing ABM dose and dose‐volume metrics in EBRT patients. By capturing clinically relevant dose heterogeneity, we have estimated a more informative exposure variable than mean ABM dose for studies on the role of radiotherapy in leukemogenesis and other adverse health effects. Future work will improve the generalizability of these methods for certain treatment regions and pediatric populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotonsBone MarrowRadiotherapy Planning, Computer-AssistedOrgans at RiskNeoplasmsPhantoms, ImagingHumansChildRadiotherapy DosageRetrospective StudiesFemaleAdultMaleChild, PreschoolAdolescentRadiotherapy, Intensity-ModulatedMiddle AgedYoung AdultAgedPrognosisInfant

Stichwörter der Autor:innen

Active bone marrowcomputational dosimetryradiotherapy

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Radiation Convergence Engineering, Yonsei University, Wonju, Gangwon, Republic of Korea.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Keith T Griffin

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Griffin, K. T., Pithadia, K. J., Yeom, Y. S., Braunstein, L., Bolton, K. L., Morton, L. M., & Lee, C. (2026). Active bone marrow dose reconstruction in a large‐scale cohort study of cancer patients treated with photon radiotherapy. Journal of Applied Clinical Medical Physics, 27(3). https://doi.org/10.1002/acm2.70494

Vancouver

Griffin KT, Pithadia KJ, Yeom YS, Braunstein L, Bolton KL, Morton LM, et al. Active bone marrow dose reconstruction in a large‐scale cohort study of cancer patients treated with photon radiotherapy. Journal of Applied Clinical Medical Physics. 2026;27(3). doi:10.1002/acm2.70494

BibTeX
@article{Griffin2026,
  author = {Griffin, Keith T and Pithadia, Kishan J and Yeom, Yeon Soo and Braunstein, Lior and Bolton, Kelly L and Morton, Lindsay M and Lee, Choonsik},
  title = {Active bone marrow dose reconstruction in a large‐scale cohort study of cancer patients treated with photon radiotherapy},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  volume = {27},
  number = {3},
  doi = {10.1002/acm2.70494}
}
Kostenlos starten →